Projected 2019 revenue for top drugs approved U.S. 2014

Published by Statista Research Department, Mar 27, 2015
This statistic displays the projected 2019 revenue for top drugs approved in the U.S. in 2014. Opdivo, approved on December 22, 2014, and developed by Bristol-Myers Squibb, is estimated to generate 3.61 billion U.S. dollars of revenue in 2019.

Projected 2019 revenue for top drugs approved in the U.S. in 2014 (in billion U.S. dollars)

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

March 2015

Region

United States

Survey time period

2014 and 2015

Open this statistic in...
Spanish
Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

10

Other regions

10

Related statistics

10

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Biotechnology in SpainGlobal pharmaceutical industryBiotech drugsBiotechnology industry in Germany Biotechnology in Europe
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu